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Anthracene Bisureas as Powerful and Accessible Anion Carriers
Christopher M. Dias,[a] Hennie Valkenier,*[b] and Anthony P. Davis*[a]
Abstract: Synthetic anion carriers (anionophores) have po-
tential as biomedical research tools and as treatments for
conditions arising from defective natural transport systems
(notably cystic fibrosis). Highly active anionophores that are
readily accessible and easily deliverable are especially valua-
ble. Previous work has resulted in steroid and trans-decalin
based anionophores with exceptional activity for chloride/ni-
trate exchange in vesicles, but poor accessibility and deliver-
ability. This work shows that anthracene 1,8-bisureas can
fulfil all three criteria. In particular, a bis-nitrophenyl deriva-
tive is prepared in two steps from commercial starting mate-
rials, yet shows comparable transport activity to the best
currently known. Moreover, unlike earlier highly active sys-
tems, it does not need to be preincorporated in test vesicles
but can be introduced subsequent to vesicle formation. This
transporter also shows the ability to transfer between vesi-
cles, and is therefore uniquely effective for anion transport
at low transporter loadings. The results suggest that anthra-
cene bisureas are promising candidates for application in
biological research and medicine.
Introduction
The transport of anions across biological membranes is essen-
tial for the proper functioning of a cell.[1, 2] Anion concentration
gradients play an important role in helping to regulate cell pH,
maintaining cell volume, and electrical signaling.[1–3] These gra-
dients are maintained and controlled through the action of
membrane-bound proteins, which provide pathways through
the apolar phospholipid bilayer.[1, 3–5] Dysfunction of these pro-
teins is known to give rise to a number of diseases including
Bartter syndrome,[6, 7] Dent’s disease,[8] and cystic fibrosis.[9, 10]
Synthetic anion transporters (anionophores) that can mimic
the function of endogenous ion transport proteins could po-
tentially be used to treat these conditions and their develop-
ment has become an active area of supramolecular chemis-
try.[4, 11,12]
An important goal in this area is the development of anion
carriers that are (a) highly active, (b) easily synthesized, and
(c) readily delivered to bilayer membranes. We have shown
that ureas and thioureas in the cholapod (1)[13–19] and trans-
decalin (2)[15,17,20–22] series (Figure 1) can serve as highly effec-
tive chloride transporters in large unilamellar vesicles (LUVs).
The most powerful, such as bisthioureas 1b and 2b (Figure 2),
can promote significant Cl@/NO3
@ exchange when present as
single molecules in LUV membranes.[15] Trans-decalin 2b, the
most active reported to date, transports 850 Cl@ ions per
second and is comparable to a protein channel after allowing
for molecular weight.[15] However, while these carriers show
high intrinsic activities, both families require quite lengthy syn-
theses. Moreover, the most active variants tend to be highly
lipophilic, and do not transfer well to a preformed membrane.
To express their activity, it is generally necessary to incorporate
them in the bilayer during membrane production. Meanwhile
Figure 1. Scaffolds upon which powerful anionophores have previously
been developed.
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other, simpler scaffolds also yield powerful anionophores (e.g. ,
3–6,[23–28,50] Figure 1), but none seem able to match the activi-
ties of the cholapod and trans-decalin families.
A key feature of transporters 1 and 2 is the 1,5-diaxial ar-
rangement of (thio)urea binding units. Parallel bonds between
scaffold and (thio)urea position the latter so that all four NH
can bind to Cl@ simultaneously. Restricted rotation about these
C@N bonds ensures that intramolecular hydrogen bonding
cannot occur. Considering alternative structures that might be
easier to synthesize, we realized that the 1,8-disubstituted an-
thracenes 7 (Figure 3) bear a close geometric resemblance to
the 1,5-diaxial systems. Compounds 7 have previously been
shown to function as receptors for anions[29–32] and neutral
guests,[33] but anionophore activity has not been investigated.
Here, we report that anthracene bisureas 7 (X=O) can serve as
outstandingly effective anionophores, competitive with the
best of the 1,5-diaxial systems and superior in some respects.
Given its accessibility, this system could be considered the




Previous work has shown that electron-withdrawing terminal
groups favor binding and transport in (thio)urea-based aniono-
phores. 4-Nitrophenyl N, 4-trifluoromethylphenyl F, and 3,5-
bis(trifluoromethyl)phenyl (F2) (Figure 3) are especially well-
known and effective.[14–17,20, 23–25,27,28,34, 35] We therefore targeted
anthracene-based bisureas bearing these substituents (7ON,
7OF, and 7OF2 ; Figure 3), with unsubstituted bisurea 7OP and
the bisthiourea 7SF2 included for comparison purposes.
Molecular modeling on 7ON confirmed the potential for chlo-
Figure 2. Structures of previously reported anionophores based on cholapod
(1) and trans-decalin (2) scaffolds.
Figure 3. a) General structure 7 of anthracene 1,8-bis(thio)ureas that have previously been applied as receptors. b) Terminal groups R used in this work. Mole-
cules are labeled according to scaffold (7), X (O/S) and aromatic substituent (P/N/F/F2). For example, 7ON refers to the bis-N-nitrophenylurea based on scaf-
fold 7.
Figure 4. a) Calculated ground-state structure of 7ON (Monte Carlo Molecu-
lar Mechanics, followed by Hartree–Fock 6-31G** optimization in Jaguar).
b) Calculated structure of 7ON·Cl@ , employing similar methodology.[39]
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ride binding and transport. The calculated ground state struc-
ture, shown in Figure 4a, features roughly antiparallel urea
groups. Although not preorganized for binding, they do not
hydrogen bond to each other and are therefore free to rotate.
On addition of chloride, the ureas adopt a convergent confor-
mation to form a 1:1 complex, with H··Cl distances of 2.3–2.5 a
(Figure 4b). These distances are slightly shorter than the hy-
drogen bonds observed in a crystal structure of a decalin 2
with Cl@ .[17] The anthracenyl C(9)-H atom is also positioned
close to the chloride (H··Cl=2.7 a), potentially contributing to
binding.[29]
The bis(thio)ureas were prepared by means of a short and
straightforward process from the commercially available (and
inexpensive) 1,8-dinitroanthraquinone (8) (Scheme 1). Follow-
ing literature procedures, 8 could be converted to diamine 10
by means of a single-step reduction with NaBH4
[33] (31% yield)
or in two steps via diaminoquinone 9 (59% overall
yield).[29,30,32] One further step is then required to generate the
bis(thio)ureas, through treatment of 10 with the appropriate
iso(thio)cyanate. Full synthetic procedures and characterization
data are given in the Supporting Information.
Binding studies
To underpin transport studies, the binding of 7 to chloride was
characterized through titrations against Bu4N
+Cl@ in
[D6]DMSO/0.5% H2O. Significant downfield shifts were ob-
served for the (thio)urea NH and C(9)@H anthracenyl signals
upon the addition of guest, which corroborates the computa-
tional prediction. To determine the stoichiometry of the host–
guest complex(es) formed, we followed the approach outlined
by Jurczak[36] and Thordarson,[37,38] whereby titration data is
fitted to all reasonable binding models (1:1, 1:2, and 2:1) and
the residual distribution plots compared. The model which
yields the lowest and most random distribution of residuals is
the most likely to be valid.[39] For bisureas 7OP, 7ON, 7OF, and
7OF2, a 1:1+2:1 (host:guest) binding stoichiometry was infer-
red and titration data were fitted to this model. Association
constants calculated for the 1:1 complex were +2000m@1, sig-
nificantly higher than that for decalin bisurea 2a (Table 1). This
is remarkable when one compares the accessibility of the an-
thracene system with that of the decalins. The affinities are
also higher than receptors based upon other simple scaffolds,
for example, 3–6, where binding constants measured under
the same conditions do not typically exceed 103m@1.[23–28,50]
The affinities are only modestly influenced by the electronic ef-
fects exerted by the terminal aryl groups, although unsubsti-
tuted bisurea 7OP was found to be the weakest chloride re-
ceptor as anticipated. In the case of bisthiourea 7SF2, analysis
indicated much weaker binding, with Ka,1:1=130m
@1. This find-
ing runs counter to normal expectation, given that thioureas
are more acidic than ureas.[40–42] However, calculations suggest
that the bulk of the thiourea S might disfavor the near-planar
conformation required for strong binding.[39] A similar phenom-
enon has previously been observed in receptors based on scaf-
fold 6, which are structurally related.[43]
Anion transport
Anion transport by 7 was assessed using the previously report-
ed lucigenin assay for Cl@/NO3
@ exchange.[44] Briefly, LUVs
(ca. 200 nm diameter) containing aqueous NaNO3 (225 mm)
and the halide-sensitive dye lucigenin were prepared from 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
cholesterol (7:3 ratio) with the test anionophore preincorporat-
ed in the membrane. The LUVs were suspended in aqueous
NaNO3 (225 mm) and placed inside a fluorescence spectrome-
ter. The experiment was commenced by the addition of NaCl
Scheme 1. Synthesis of anthracene bis(thio)ureas: (i) Na2S·9H2O, EtOH/H2O,
reflux, 65 h, 98%; (ii) NaBH4, NaOH, iPrOH, reflux, 16 h, 60%; (iii) NaBH4,
iPrOH, reflux, 43 h, 31%; (iv) 7O(P/N/F/F2): ArNCO, CH2Cl2, reflux, 4–16 h, 50–
90%, 7SF2 : 3,5-(CF3)2C6H3NCS, pyridine, RT, 21 h, 61%.
Table 1. Binding and transport data for bis(thio)ureas in the cholapod
(1), trans-decalin (2), and anthracene (7) series.









[e] [I] [s@1][f] D[i]
1a[15, 17] 12.0 n.d. – 64 450 0.12
1b[15, 17] 10.2 17000[c] – 15 1800 0.37
2a[15] 11.3 880[c,j] – 88 340 n.d.
2b[15, 45] 11.6 2600[c] – 9 3800 0.03
7OP 7.3 2000[d] 240[d] 277 90 1
7ON 6.9 2600[d] 210[d] 22 2100 0.82
7OF 9.3 2200[d] 250[d] 45 1200 0.62
7OF2 11.4 3000[d] 390[d] 30 1900 0.45
7SF2 11.7 130[g] [g] [h] [h] n.d.
n.d.=not determined. [a] Calculated logP, an estimate of lipophilicity.
Values were calculated using TorchLite (available as freeware from
www.cresset-group.com). [b] Obtained through 1H NMR titrations at
298 K. [c] Obtained by fitting all data points to a 1:1 binding model using
a least-square fitting procedure. [d] Obtained by fitting all data points to
a 1:1+2:1 (receptor:chloride) binding model (Nelder–Mead method)
using the Bindfit v0.5 applet (available as freeware from app.supramole-
cular.org). [e] Obtained by fitting F0/F versus time (0–500 s) to a single ex-
ponential decay function when transporter :lipid=1:25k. [f] Specific initial
rate: initial slope for F0/F versus time, divided by transporter/lipid ratio
and averaged for a range of experiments at different loadings. [g] Ob-
tained by fitting all data points to a 1:1+1:2 binding model (method as
for [d] above) ; Ka,1:2=14m
@1. [h] Transport was observed (see Figure 5a)
but not quantified, due to the instability of 7SF2 in the medium.[39] [i] D=
deliverability. Calculated by dividing I for the external addition experi-
ment by that observed when the anionophore was preincorporated.
[j] Measured for the ethyl ester analogue of 2a. The ester side-chain is
not expected to affect affinities.[15]
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(25 mm) and the influx of chloride monitored by the decay in
lucigenin fluorescence.[39]
Transport rates were quantified by fitting the inverse of the
normalized fluorescence traces (F0/F) to single exponential
function to obtain approximate half-lives (t1=2) and a double ex-
ponential function to obtain initial rates (I). Dividing I by the
transporter/lipid ratio and averaging for a range of experi-
ments at different loadings gives the specific initial rate, [I] . As
described in previous work,[15] [I] is independent of the trans-
porter to lipid loading and thus allows the performance of
anionophores with widely different activities to be compared
directly.
Results from these experiments are summarized in Table 1
and Figure 5. All the anthracene bisureas were found to medi-
ate chloride transport, with activities measurable at transporter
to lipid loadings as low as 1:250k (1.6 nm overall in the aque-
ous suspension) (Figure 5b). Consistent with previous observa-
tions,[15, 16,20,25, 28,34,35] the electron-deficient aryl termini N, F, and
F2 promoted faster transport than unsubstituted P. The most
powerful variant was the nitrophenyl bisurea 7ON, for which [I]
was measured as 2100 s@1. A dose-response study employing
six different loadings of 7ON (Figure 6a) revealed that this
compound was significantly active even at the lowest trans-
porter to lipid ratio of 1:1000k. At this loading most LUVs con-
tain either 1 or 0 transporter molecules, thus the activity ob-
served corresponds to 7ON acting as a single molecule.[15]
Comparing 7ON to earlier systems, the anthracene does not
quite match decalin 2b, the current record-holder at [I]=
3800 s@1. However, the examination of fluorescence decay
traces shows that in some respects the new system is more ef-
fective. We have previously found that powerful transporters
such as 2b and 1b produce rapid initial drops in emission at
the low loadings, but that traces tend to plateau at relatively
high levels. This is illustrated in Figure 7 for transporter :lipid=
Figure 5. Chloride transport mediated by anthracene-based bis(thio)ureas in
200 nm POPC/cholesterol (7:3) LUVs as measured using the lucigenin
method. The anionophore was preincorporated in the membrane at a trans-
porter to lipid loading of a) 1:25k or b) 1:250k.
Figure 6. Chloride transport mediated by 7ON in 200 nm POPC/cholesterol
(7:3) LUVs when preincorporated at various transporter to lipid loadings.
(a) Traces for F/F0 versus time. (b) Plot of the initial rate of transport induced
by 7ON as a function of its concentration inside LUVs.
Figure 7. Chloride transport mediated by compounds 1b, 2b, and 7ON in
200 nm POPC/cholesterol (7:3) LUVs as measured using the lucigenin
method. The anionophore was preincorporated in the membrane at a trans-
porter to lipid loading of 1:250k in all cases.
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1:250k. We believe this is due to the absence of transporter
molecules from many vesicles (see above), which therefore act
as bystanders. In contrast, the traces for 7ON tend towards
lower emission values at all loadings (Figures 6a and 7). Thus,
as the experiment progresses, the overall effect of 7ON be-
comes greater than any of the earlier systems. The reason for
the difference is thought to be the ability of 7ON to transfer
between vesicles, unlike 2b, which is trapped in its original lo-
cation. Experiments supporting this hypothesis are described
in the next section.
Considering their accessibility, the effectiveness of the an-
thracene bisureas is remarkable. In contrast to decalin 2b,
which requires a nine-step synthesis,[15] the anthracenes are
available in just two steps. Moreover, it is notable that 7ON
and 7OF2 are ureas, whereas 2b possesses the more favorable
thiourea units. Decalin bisurea 2a is considerably less active
than the anthracene bisureas, suggesting that the anthracene
scaffold is more effective than the decalin. It is more difficult
to compare the transporters with systems from other groups,
but the dose-response data for 7ON (Figure 6) allows the esti-
mation of an EC50,270s,
[46] a measure which is widely used by
other laboratories. The EC50,270s value calculated for 7ON is
0.0003 mol%, the lowest reported to date for chloride–nitrate
exchange, and even lower than that of the natural aniono-
phore prodigiosin.[28]
In contrast to the ureas, and counter to trends observed pre-
viously,[15] the bisthiourea 7SF2 proved relatively ineffective
(Figure 5a). While its modest chloride affinity may be a factor,
it also showed limited stability under the conditions of the
transport experiment.[39] The anthracene bisthiourea design
was therefore not pursued further.
Mechanistic studies
Although the anthracene bisureas were designed as anion car-
riers, it is also possible that they could act through formation
of self-assembled channels. The linear relationship between ini-
tial transport rates and transporter :lipid ratios for 7ON (Fig-
ure 6b) provides one line of evidence for the carrier mecha-
nism; if more than one transporter molecule is required to
form the active complex, one would normally expect reduced
effectiveness at lower concentrations.[47] To support this con-
clusion, transport was also studied in vesicles composed of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), which un-
dergoes a transition between gel and liquid phases at 41 8C.[48]
The transition is expected to affect transport rates for mobile
carriers, but much less so for channels. As anticipated, 7ON
proved inactive at 25 8C (gel phase), but active at 45 8C (liquid
phase), consistent with the carrier mechanism.[39,49]
Studies were also undertaken to test the ability of the trans-
porters to move between vesicles, as implied for 7ON by the
results discussed earlier. “Delivery vesicles” containing 7ON but
not lucigenin were mixed with “receiver vesicles” containing
lucigenin but not 7ON, before addition of chloride. Fluores-
cence decay traces implied that the transporter was transferred
rapidly to the receiver vesicles, equilibration occurring in
,5 min.[39] In contrast, the same experiments with the more
lipophilic 7OF2 showed negligible transfer on the same time-
scale. Despite the ability of 7ON to exchange between vesicles,
experiments designed to detect leaching from the membranes
gave negative results, implying that the equilibrium concentra-
tion in water is very low.[39]
Deliverability
An important requirement for practical applications of aniono-
phores is that they must be readily deliverable to target mem-
branes. The most active cholapod and trans-decalin carriers do
not fulfil this criterion well. Decalin 2b, in particular, is almost
inactive when added to preformed LUVs and is only effective
when incorporated in the vesicles as they are prepared.[15,45] To
provide a quantitative estimate of deliverability, we have devel-
oped a variant of the lucigenin assay in which the vesicles are
formed without transporter, and the latter is then added using
a standardized procedure, before the introduction of chlo-
ride.[17] The decay of F0/F is followed, and the initial rate I is
measured. Deliverability (D) is quantified by dividing I for this
experiment by that observed when the anionophore was pre-
incorporated. Fluorescence decay traces for both types of ex-
periment, applied to the four anthracene bisureas, are shown
in Figure 8. Values of D for the anthracene bisureas, as well as
Figure 8. Chloride transport mediated by anthracene bisureas when the
anionophore was either preincorporated in the membrane (solid lines) or
added externally as solution in DMF to vesicles without anionophore
(dashed lines). The notional transporter to lipid loading was 1:25k for 7OP
and 1:250k for 7ON, 7OF, and 7OF2.
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1a, 1b, and 2b, are listed in Table 1. The results show that de-
liverability for 7OF and 7OF2 is only moderate, but that 7OP
and 7ON are transferred quite efficiently to the vesicles. In par-
ticular, the deliverability of 7ON, at D=0.82, contrasts starkly
with that of 2b (D=0.03). The good deliverability of 7ON
probably relates to its moderate lipophilicity (c logP=6.9, see
Table 1). We suspect that highly lipophilic agents such as 2b
(c logP=11.6) form intractable aggregates after addition to the
aqueous phase, and these interact poorly with the membranes.
Though 7ON presumably also aggregates, the individual mole-
cules are less lipophilic and this could lead to improved availa-
bility.
Conclusion
In conclusion, we have shown that anthracene 1,8-bisureas are
exceptionally effective and practical anion transporters. The
most powerful promote chloride/nitrate exchange at rates
comparable to the highest previously observed, while being
far more accessible than the earlier systems. Dinitro variant
7ON combines high activity with good deliverability in a
manner unmatched by previous systems. Taking into account
its ability to transfer between vesicles, it is arguably the most
effective agent currently available for transporting chloride
across vesicle membranes at low dosages. The anthracene scaf-
fold has potential for further modification to control binding
affinities, lipophilicities etc. We believe the design has promise
for application in tools for biomedical research, and perhaps in
the treatment of channelopathies such as cystic fibrosis.
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